LSE:HEMO   HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01
Massive winner today Hemogenyx (HEMO) moved 55% in 1.5h before market close on the news drop of working closely and in agreement with Eli Lilly. The correction has been clearly completed and there were already signs of this impulse up with the sub wave 1 and then sub wave 2 correction days ago. The larger Wave 2 is complete already and we are in the most bullish phase now.
Targets are marked for the wave 3 upside, of course it can extend well further than the conservative targets of 1:1 and x1.618 extension only.
Hemo is working closely so far with 2 giant Pharma companies. Their research is truly significant and has a massive potential in their future value.
The mcap is well undervalued on this future potential and on the recent news.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。